Abstract:e16574 Background: Renal cell carcinoma (RCC) is the second most common malignant tumor of the urinary system in China. With the extension of the life expectancy of the population, the incidence of kidney cancers have shown gradually increasing trends and been commonly detected in patients aged 65 years and older with the mortality rate of 67.7%, most of whom suffered poor renal functional preservation or multiple comorbidities. Compared to partial nephrectomy (PN), microwave ablation (MWA) has been considered as one of the best indications for selected clinical T1 (cT1) RCC in elder patients. The purpose of the study was to evaluate the clinical results of patients aged 65 years and older with cT1 RCCs treated by percutaneous microwave ablation under ultrasound (US) guidance, compared to those less than 65. Methods: From September 2009 to December 2016, clinical data of MWA treatment for RCCs in two groups with the similar mean diameters in baseline, Group O (65 years and older) including 75 patients with 76 RCCs and Group Y (less than 65 years) including 91 ones with 99 RCCs, were retrospectively assessed. The technical efficacy, cumulative overall survival (OS) and disease-free survival (DFS), local tumor progression (LTP), major and minor complications, and renal function including serum creatinine (Cr) and blood urea nitrogen (BUN) between the two groups were statistically evaluated by SPSS. Results: After ablation, there were no statistical significances between the two groups at technical efficacy, LTP, major and minor complications. The cumulative OS and DFS rates at 1, 3, 5 years in Group O vs. Group Y were 100%, 92.6%, 92.6% vs. 100%, 96.9%, 90.9% (p = 0.701) and 100%, 92.5%, 92.5% vs. 98.6%, 98.6%, 90.4% (p = 0.697), respectively. There were no significant differences both serum Cr and BUN between the two groups before MWA and at the last follow-up. Conclusions: Compared to those less than 65 years, US-guided percutaneous MWA for cT1 RCCs could achieve coincident clinical results in patients 65 years and older, and then can be recommended one of optimal alternative treatment for selected older patients.

Safety and Clinical Outcomes of Computed Tomography‐guided Percutaneous Microwave Ablation in Patients Aged 80 Years and Older with Early‐stage Non‐small Cell Lung Cancer: A Multicenter Retrospective Study

Percutaneous Microwave Ablation under Ultrasound Guidance for Renal Cell Carcinomas at Clinical Staging T1: A Comparative Study of Clinical Results for Patients Aged Between Less Than 65 Years and 65 Years and Older.

Microwave Ablation for Inoperable Stage I Non-Small Cell Lung Cancer in Patients Aged 70 Years: A Prospective, Single-Center Study

Analysis of Percutaneous microwave coagulation therapy for aged peripheral lung cancer patient

US-guided Percutanous Microwave Ablation for Early-Stage Hepatocellular Carcinoma in Elderly Patients is As Effective As in Younger Patients: A 10-Year Experience

Safety and Effectiveness Analysis of Percutaneous Microwave Thermal Ablation Therapy Combined Brachytherapy for Lung Malignant Lesion

A Feasibility and Safety Study of Computed Tomography-Guided Percutaneous Microwave Ablation: a Novel Therapy for Multiple Synchronous Ground-Glass Opacities of the Lung

Percutaneous Microwave Ablation under Ultrasound Guidance for Renal Cell Carcinomas at Clinical Staging T1 in Patients Aged 65 Years and Older: A Comparative Study

CT-guided Percutaneous Microwave Ablation of Pulmonary Malignancies: Results in 69 Cases

Percutaneous Microwave Ablation of Stage I Medically Inoperable Non‐small Cell Lung Cancer: Clinical Evaluation of 47 Cases

Computed tomography-guided percutaneous microwave ablation for treatment of peripheral ground-glass opacity–Lung adenocarcinoma: A pilot study

Prognosis of Microwave Ablation for Hepatocellular Carcinoma: Does Age Make a Difference?

Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC

Clinical and Survival Outcomes of Percutaneous Microwave Ablation for Intrahepatic Cholangiocarcinoma

Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT): A Strobe-compliant observational study.

Microwave Ablation or Plus Monochemotherapy in Elderly Advanced Non-Small-cell Lung Cancer Patients.

Microwave Ablation for the Treatment of Peripheral Ground-Glass Nodule-Like Lung Cancer: Long-term Results from a Multi-Center Study.

Percutaneous Microwave Ablation Versus Breast Conserving Surgery for 2-5Cm Breast Cancer: A Two-Center, Retrospective Study

Clinical evaluation of CT-guided percutaneous microwave ablation of non-small cell lung cancer

Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results

The Application of Computed Tomography-Guided Percutaneous Coaxial Biopsy Combined with Microwave Ablation for Pulmonary Tumors